AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
The value of Cloquet's node in predicting melanoma nodal metastases in thepelvic lymph node basin
Authors: Strobbe, LJA Jonk, A Hart, AAM Peterse, JL Wobbes, T Nieweg, OE Kroon, BBR
Citation: Lja. Strobbe et al., The value of Cloquet's node in predicting melanoma nodal metastases in thepelvic lymph node basin, ANN SURG O, 8(3), 2001, pp. 209-214
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer
Authors: Tanis, PJ Boom, RPA Koops, HS Faneyte, IF Peterse, JL Nieweg, OE Rutgers, EJT Tiebosch, ATMG Kroon, BBR
Citation: Pj. Tanis et al., Frozen section investigation of the sentinel node in malignant melanoma and breast cancer, ANN SURG O, 8(3), 2001, pp. 222-226
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
Authors: Bijker, N Rutgers, EJT Peterse, JL Fentiman, IS Julien, JP Duchateau, L van Dongen, JA
Citation: N. Bijker et al., Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS, EUR J SUR O, 27(2), 2001, pp. 135-140
Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
Authors: Bijker, N Peterse, JL Duchateau, L Julien, JP Fentiman, IS Duval, C Di Palma, S Simony-Lafontaine, J de Mascarel, I van de Vijver, MJ
Citation: N. Bijker et al., Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853, J CL ONCOL, 19(8), 2001, pp. 2263-2271
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
Authors: Voogd, AC Nielsen, M Peterse, JL Blichert-Toft, M Bartelink, H Overgaard, M van Tienhoven, G Andersen, KW Sylvester, RJ van Dongen, JA
Citation: Ac. Voogd et al., Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials, J CL ONCOL, 19(6), 2001, pp. 1688-1697
Quiz case
Authors: Deurloo, EE Peterse, JL Pruijt, JFM Kool, LJS
Citation: Ee. Deurloo et al., Quiz case, EUR J RAD, 38(2), 2001, pp. 160-162
Is lymphatic mapping in breast cancer adequate and safe?
Authors: Nieweg, OE Rutgers, EJT Jansen, L Olmos, RAV Peterse, JL Hoefnagel, KA Kroon, BBR
Citation: Oe. Nieweg et al., Is lymphatic mapping in breast cancer adequate and safe?, WORLD J SUR, 25(6), 2001, pp. 780-788
Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection
Authors: Dadmanesh, F Peterse, JL Sapino, A Fonelli, A Eusebi, V
Citation: F. Dadmanesh et al., Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection, HISTOPATHOL, 38(1), 2001, pp. 54-61
Breast-conserving therapy for Paget disease of the nipple - A prospective European Organization for Research and Treatment of Cancer Study of 61 patients
Authors: Bijker, N Rutgers, EJT Duchateau, L Peterse, JL Julien, JP Cataliotti, L
Citation: N. Bijker et al., Breast-conserving therapy for Paget disease of the nipple - A prospective European Organization for Research and Treatment of Cancer Study of 61 patients, CANCER, 91(3), 2001, pp. 472-477
Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer
Authors: Kaas, R Hart, AAM Besnard, APE Peterse, JL Rutgers, EJT
Citation: R. Kaas et al., Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer, BR J SURG, 88(1), 2001, pp. 123-127
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ
Authors: Bijker, N Peterse, JL Duchateau, L Robanus-Maandag, EC Bosch, CAJ Duval, C Pilotti, S van de Vijver, MJ
Citation: N. Bijker et al., Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ, BR J CANC, 84(4), 2001, pp. 539-544
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast
Authors: Elston, CW Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Dervan, P Drijkoningen, M Eusebi, V Faverly, D Holland, R Jacquemier, J Lacerda, M Martinez-Penuela, J de Miguel, C Moss, S Munt, C Peterse, JL Rank, F Reiner, A Sylvan, M Wells, CA Zafrani, B
Citation: Cw. Elston et al., Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast, EUR J CANC, 36(14), 2000, pp. 1769-1772
Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study
Authors: Damiani, S Pasquinelli, G Lamovec, J Peterse, JL Eusebi, V
Citation: S. Damiani et al., Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study, VIRCHOWS AR, 437(1), 2000, pp. 74-81
Mammographically detected in situ lobular carcinomas of the breast
Authors: Sapino, A Frigerio, A Peterse, JL Arisio, R Coluccia, C Bussolati, G
Citation: A. Sapino et al., Mammographically detected in situ lobular carcinomas of the breast, VIRCHOWS AR, 436(5), 2000, pp. 421-430
False negative sentinel node procedure established through palpation of the biopsy wound
Authors: Tanis, PJ Nieweg, OE Merkus, JWS Peterse, JL Kroon, BBR
Citation: Pj. Tanis et al., False negative sentinel node procedure established through palpation of the biopsy wound, EUR J SUR O, 26(7), 2000, pp. 714-715
Adjuvant radiotherapy for DCIS - Authors' reply
Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL
Citation: Jp. Julien et al., Adjuvant radiotherapy for DCIS - Authors' reply, LANCET, 355(9220), 2000, pp. 2072-2073
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL Delledonne, V Rouanet, P Avril, A Sylvester, R Mignolet, F Bartelink, H Van Dongen, JA
Citation: Jp. Julien et al., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853, LANCET, 355(9203), 2000, pp. 528-533
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes
Authors: Hoebers, FJP Borger, JH Hart, AAM Peterse, JL Rutgers, EJT Lebesque, JV
Citation: Fjp. Hoebers et al., Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes, CANCER, 88(7), 2000, pp. 1633-1642
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients
Authors: Doting, MHE Jansen, L Nieweg, OE Piers, DA Tiebosch, ATMG Koops, HS Rutgers, EJT Kroon, BBR Peterse, JL Olmos, RAV de Vries, J
Citation: Mhe. Doting et al., Lymphatic mapping with intralesional tracer administration in breast carcinoma patients, CANCER, 88(11), 2000, pp. 2546-2552
Reliability of sentinel lymph node biopsy for staging melanoma
Authors: Jansen, L Nieweg, OE Peterse, JL Hoefnagel, CA Olmos, RAV Kroon, BBR
Citation: L. Jansen et al., Reliability of sentinel lymph node biopsy for staging melanoma, BR J SURG, 87(4), 2000, pp. 484-489
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer
Authors: Voogd, AC Peterse, JL Crommelin, MA Rutgers, EJT Botke, G Elkhuizen, PHM van Geel, AN Hoekstra, CJM van Pel, R van de Vijver, MJ Coebergh, JWW
Citation: Ac. Voogd et al., Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer, EUR J CANC, 35(13), 1999, pp. 1828-1837
Prognosis after treatment for loco-regional recurrence after mastectomy orbreast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)
Authors: van Tienhoven, G Voogd, AC Peterse, JL Nielsen, M Andersen, KW Mignolet, F Sylvester, R Fentiman, IS van der Schueren, E van Zijl, K Blichert-Toft, M Bartelink, H van Dongen, JA
Citation: G. Van Tienhoven et al., Prognosis after treatment for loco-regional recurrence after mastectomy orbreast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM), EUR J CANC, 35(1), 1999, pp. 32-38
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas
Authors: Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Eusebi, V De Miguel, C Dervan, P Drijkoningen, R Elston, CW Faverly, D Gad, A Jacquemier, J Lacerda, M Martinez-Penuela, J Munt, C Peterse, JL Rank, F Sylvan, M Tsakraklides, V Zafrani, B
Citation: Jp. Sloane et al., Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas, VIRCHOWS AR, 434(1), 1999, pp. 3-10
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer
Authors: Voogd, AC van der Horst, F Crommelin, MA Peterse, JL van Beek, MWPM van Driel, OJR van der Heijden, LH Coebergh, JWW
Citation: Ac. Voogd et al., The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer, EUR J SUR O, 25(3), 1999, pp. 273-279
Lymphatic mapping and sentinel lymph node biopsy in breast cancer
Authors: Nieweg, OE Jansen, L Olmos, RAV Rutgers, EJT Peterse, JL Hoefnagel, KA Kroon, BBR
Citation: Oe. Nieweg et al., Lymphatic mapping and sentinel lymph node biopsy in breast cancer, EUR J NUCL, 26(4), 1999, pp. S11-S16
Risultati: 1-25 | 26-29